Serum biochemical analyses were done on F344 rats in the early and late stages of mononuclear cell leukemia. There were marked increases in serum bilirubin, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase and alkaline phosphatase. Increases in these parameters generally were more severe in the late stages of leukemia. Both direct and indirect-reacting bilirubin were increased with the unconjugated form predominating early and the conjugated form predominating late in the course of the disease. Lactate dehydrogenase isoenzyme determination correlated with histological examination indicated that liver damage was responsible for the observed changes. Urinalysis revealed marked hemoglobinuria, bilirubinuria and increased urine urobilinogen. Serum protein electrophoresis revealed marked reductions in the alpha globulin fractions.
Mononuclear cell leukemia initially was recognized in Wistar Furth rats [ 101 and then F344 rats [9] in 1970. Since that time mononuclear cell leukemia has been reported in several studies on spontaneous diseases of F344 rats [2, 3, 7, 14, 151 . Recently a more complete characterization of the lesions noted frequent and extensive infiltration of the hepatic sinusoids as well as severe hepatocellular degeneration and necrosis often [ 161. Hemostasis tests demonstrated prolonged prothrombin times and marginally elevated partial thromboplastin times as well as hypofibrinogenemia [ 171. These changes suggest potential derangements in liver function. The frequent occurrence of mononuclear cell leukemia in Fischer rats makes it likely that interpretation of clinical chemistry data in chronic toxicity studies will be obscured by alterations induced by the disease. This study was initiated to define these changes so toxicologic pathologists could interpret clinical chemistry data from experimental rats more precisely as well as to more completely characterize the lesions in the liver of rats with mononuclear cell leukemia.
Materials and Methods
Rats were obtained from control groups on two-year chronic toxicity and carcinogenicity studies. The rats were anesthetized with intraperitoneal injection of pentobarbital sodium just before necropsy. A ventral midline incision was made and blood was collected from the caudal vena cava using a 20 g needle and a 10 cc syringe. Blood was transferred to a 5 cc tube, allowed to clot, centrifuged and the serum was collected and frozen. Determinations of alkaline phosphatase and lactate dehydrogenase isoenzymes were done on fresh, unfrozen serum. Samples of liver were preserved in 10% neutral buffered formalin and routinely processed for histological examination.
Serum chemical determinations were done with a Gemsaec centrifugal analyzer (Electro-Nucleonics, Inc., Fairfield, N.J.). Spinchem reagents (Smith Kline Instruments, Inc., Sunnyvale, Calif.) were used in the determination of glucose, urea nitrogen, creatinine, cholesterol, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, lactate dehydrogenase, calcium and phosphorus. Bilirubin and total protein were determined using reagent kits manufactured by Electro-Nucleonics, Inc. Sodium and potassium were determined by flame photometry using a n IL 143 flame photometer (International Laboratories, Lexington, Mass.). Urine chemistry was evaluated using Multistix reagent strips (Ames Division, Miles Laboratories, Elkhart, Ind.) and freshly expressed urine. Fecal occult blood determination utilized the Hemoccult slide method (Smith Kline Diagnostics). Lactate dehydrogenase isoenzymes were determined using the Super LDH isoenzyme kit (Helena Laboratories, Beaumont, Tx.). Electrophoresis was done using Titan 111 Is0 Vis cellulose acetate plates (Helena Laboratories) with a charge of 300 V applied for ten minutes. The barbital buffer used in this system was Electra H R Buffer (Helena Laboratories) at pH 8.7. Samples of 1.0 pl of serum were applied to the plates with a micropipette. After electrophoresis, substrate was applied using a sandwiching technique and incubated for I5 minutes at 37°C. Plates were scanned wet on a Quick Scan (Helena Laboratories) densitometer at 570 nm and a slit width of 0.5 mm. Results were expressed as absolute values of IU/I of isoenzymes.
Serum protein electrophoresis was done using cellulose acetate plates with a charge of 200 V applied for 22 minutes. Barbital buffer was Electra H R Buffer at 0.5 ionic strength, pH 8.7. Serum (0.5 p l ) was applied with a commercial micropipette. Plates were stained with Ponceau S, destained with 5% acetic acid, and cleared with propylene glycol-methanol. Plates were scanned on a Quick Scan densitometer at 570 n m and slit width of 0.2 nm. Results were expressed as absolute values (g/dl) of protein.
Rats were divided into two categories. Scheduled sacrifice rats were in the early stages of mononuclear cell leukemia and were clinically normal or mildly pale and identified as leukemic by observation of splenomegaly at the normal, predetermined necropsy date. Early death rats exhibited severe clinical illness in the terminal stages of mononuclear cell leukemia and were necropsied before the predetermined date. Data were analyzed using the Student's /-test [6] .
Results
A biochemical profile which included glucose, urea nitrogen, creatinine, cholesterol, sodium, potassium, calcium and phosphorus was done on eight scheduled sacrifice rats and 17 age-matched controls. There were no significant differences (P < 0.05) in these parameters between normal rats and those with mononuclear cell leukemia. Serum bilirubin was determined for 20 scheduled sacrifice rats, 13 early death rats, and 16 age-matched controls without evidence of mononuclear cell leukemia. Total bilirubin was increased significantly (P < 0.0 1) in scheduled sacrifice and early death rats (table I) . Values for scheduled sacrifice rats ranged from 0.54-6.05 mg/dl (mean = 1.61) while total bilirubin for early death rats ranged from 1.16-27.98 mg/dl (mean = 10.09). Analysis of the bilirubin revealed that both direct and indirect fractions were elevated. For scheduled sacrifice rats, the mean indirect bilirubin (1.4 1 mg/dl) was approximately three times the mean direct bilirubin (0.52 mg/dl), and accounted for 88% of the total. Both direct and indirect bilirubin from early death rats were increased significantly when compared to scheduled sacrifice rats. For early death rats, the mean direct bilirubin (6.60 mg/ dl) was approximately twice the mean indirect bilirubin (3.49 mg/dl) and accounted for 65% total bilirubin. Serum from these rats often was distinctly icteric-this correlated with the jaundiced clinical appearance [ 161.
Biochemical evaluation of liver involvement in mononuclear cell leukemia rats was done by determination of liver-related serum enzymes (table I) . Serum aspartate aminotransferase was assayed in 28 normal control rats and compared to values from 19 scheduled sacrifice and 13 early death rats. Mean aspartate aminotransferase was increased significantly in scheduled sacrifice rats compared to normal. Values ranged from 1 1 1-723 IU/l. The mean aspartate aminotransferase from early death rats (1963 IU/l) was increased significantly when compared to scheduled sacrifice rats (317 IU/l) and ranged from 78 to 11,140 IU/l. Serum alanine aminotransferase also was determined for 28 normal controls, 12 scheduled sacrifice, and 13 early death rats with mononuclear cell leukemia. The alanine aminotransferase values from these three groups (table I) were all significantly different. The scheduled sacrifice rats had a ?hree-fold increase and the early death rats a fourteen-fold increase in alanine aminotransferase when compared to normal. Serum alkaline phosphatase was determined for 28 normal controls and 16 scheduled sacrifice leukemic rats. No alkaline phosphatase determinations were done on early death rats. Alkaline phosphatase from scheduled sacrifice rats ranged from 94 to 205 IU/1 with a mean of 153 IU/l. This represented slightly more than a twofold increase in alkaline phosphatase over normal which was highly significant (P < 0.0 1). Serum lactate dehydrogenase was determined for eight normal controls, nine scheduled sacrifice, and 1 1 early death rats with mononuclear cell leukemia. Although there was some overlap with the normal range (83-470 IU/l), the scheduled sacrifice leukemia (302-666 IU/I) and early death leukemia range (78-11,140 IU/l), the means were significantly different from each other. The mean To increase the specificity of the serum enzyme assays and evaluate the contribution of non-hepatic tissue damage to total serum enzyme elevations, lactate dehydrogenase isoenzyme determinations were done on 1 1 scheduled sacrifice leukemic rats and compared to eight normal controls (table 11). In normal rats 72 to 73% of the total lactate dehydrogenase migrates toward the cathode as isoenzyme 5. The remaining four isoenzymes contribute approximately equal proportions to the total lactate dehydrogenase. The leukemic rats exhibited significant elevations of isoenzymes 2 through 5 (P < 0.5) and no change in isoenzyme 1. Although the greatest increase occurred in isoenzyme 4 in the leukemic rats (eight-to nine-fold increase), isoenzyme 5 contributed the most to the total elevations. Isoenzymes 4, 3 , and 2 each contributed successively lower proportions to the total increase. Figure 1 illustrates the difference in the lactate dehydrogenase isoenzyme patterns between normal and a leukemic rat. It is clear that there was an increase in the isoenzymes on the cathodal end.
Urine chemistry was done on ten early death leukemic rats and compared to four age-matched normal controls (table 111) . Urine from leukemic rats was generally clear and deep yellow to amber in color. Sediment analysis revealed abundant mucoid proteinaceous material but no cells. There were markedly elevated levels of urine urobilinogen, bilirubin, and blood. With the absence of erythrocytes in the urine sediment, the presence of blood was interpreted as hemoglobin. The degree of bilirubinuria and urobilinogenuria generally reflected the clinical appearance of the rats with the greatest quantities found in the most juandiced rats. Two of the ten leukemic rats were negative for urine hemoglobin and bilirubin. These rats had elevated indirect serum bilirubin, normal direct bilirubin, and elevated urine urobilinogen.
Fecal occult blood determinations were done on eight rats. One rat was positive for occult blood.
Total serum protein and protein electrophoresis was done on nine age-matched (table IV) . In general, changes were more pronounced in the early death rats compared to normal. This was due primarily to decreases in the alpha globulin fractions. Mean alpha 1 globulins were 0.72 g/dl for scheduled sacrifice and 0.49 g/dl for early death leukemic rats, respectively. These values were significantly different from each other as well as from normal (P < 0.05) and
represent levels of alpha 1 globulin which are 72% and 49% of normal. The alpha 2 globulin fraction was decreased significantly in leukemic rats compared to normal, with levels in the early death rats reaching 68% of normal. There was a mild but significant increase in the beta 1 globulin fraction between normal and leukemic rats. Beta 2 globulins exhibited a mild but significant increase in the scheduled sacrifice rats, but early death rats were the same as normal. Likewise, there was a mild decrease in albumin in the scheduled sacrifice rats but levels in the early death rats were not significantly different from normal. No significant differences in the gamma globulin fraction were noted in the leukemic rats.
Discussion
Hyperbilirubinemia was a consistent finding in rats with mononuclear cell leukemia. Twelve of 20 scheduled sacrifice rats and 13 of 13 early death rats exhibited total bilirubin values greater than the 95% confidence interval for normal. The more frequent occurrence of hyperbilirubinemia (and of higher magnitude) in early death rats than in scheduled sacrifice rats indicates a progressive increase in the serum bilirubin levels from early to late in the disease. This correlated with the clinical observation of jaundice which was common in early death rats but never noted in scheduled sacrifice rats. Examination of the proportions of direct and indirect bilirubin indicates significant increases in both fractions. However, a fundamental difference in the hyperbilirubinemia was noted when comparing scheduled sacrifice and early death rats. The scheduled sacrifice rats had a threefold increase in total bilirubin and a 3 to 1 ratio of indirect to direct fraction. This indicates that early in the disease hyperbilirubinemia was due primarily to hemolysis. The early death rats, on the other hand, exhibited a two-fold increase in indirect bilirubin from scheduled sacrifice rats but a thirteen-fold increase in direct bilirubin. The ratio of indirect to direct bilirubin was approximately 1 to 2. The reversal in the indirect to direct bilirubin ratio in early death rats indicates an increased role for hepatocellular disease late in the pathogenesis of the hyperbilirubinemia. The progressive increase in hepatocellular degeneration and necrosis with probable biliary obstruction noted between scheduled sacrifice and early death rats [ 161 reduced the capacity of excretion of the glucuronide conjugated bilirubin in the face of increased unconjugated bilirubin generated by hemolysis.
The results of the urinalysis from mononuclear cell leukemia rats is consistent with an interpretation of hemolytic disease with secondary liver disease. Since indirect or unconjugated bilirubin does not normally pass the glomerular filter, and the diazotization method of detection on the Multistix is insensitive for indirect bilirubin [4] , the bilirubinuria found in mononuclear cell leukemia rats is interpreted as conjugated. This correlates closely with high levels of direct or conjugated bilirubin in the serum of mononuclear cell leukemia rats. Conjugated bilirubinemia and bilirubinuria will accompany hemolytic disease if secondary liver disease is present [4] . The marked elevation in urine urobilinogen is due to increased formation in the intestine from hemolysis. Increased absorption and reduced clearance from the enterohepatic circulation by damaged hepatocytes results in increased renal excretion of urobilinogen [4] . The histological findings of severe liver disease in mononuclear cell leukemia [ 161 are consistent with the observed changes in urine chemistry.
The presence of a 2+ or 3+ reaction for blood in the urine coupled with the absence of erythrocytes and low protein indicates a diagnosis of either hemoglobinuria and/or myoglobinuria [4] . The occurrence of reddish tinged serum, hemolytic anemia [17] and no histological evidence for muscle necrosis [16] suggests a diagnosis of hemoglobinuria secondary to intravascular hemolysis in mononuclear cell leukemia rats. This is further supported by the histological demonstration of both hemosiderin and hemoglobin in the proximal convoluted tubular epithelium
The elevation in both alanine aminotransferase and aspartate aminotransferase was moderate in the scheduled sacrifice rats and severe in the early death rats. Both enzymes are present in the rat liver and are increased in serum during chemical damage to hepatocytes [8] . Increased alanine aminotransferase is relatively specific for liver damage while increased aspartate aminotransferase may originate from other tissues-notably cardiac and skeletal muscles [ 51. Histological examination of 205 mononuclear cell leukemias revealed a low incidence of neoplastic infiltration of muscle [ 161. Thus, it is likely that the elevation in aspartate aminotransferase activity in mononuclear cell leukemia is due to the hepatocellular disease secondary to leukemic infiltration or hypoxia from anemia. The magnitude of elevation in these enzymes correlated well with the severity of leukemia involvement.
The elevation of serum lactate dehydrogenase in mononuclear cell leukemia rats paralleled the increases in alanine aminotransferase and aspartate aminotransferase. There was significant increase in lactate dehydrogenase in the scheduled sacrifice rats and severe increases in the early death rats. Increased serum lactate dehydrogenase has been correlated with chemical-induced liver damage in rats [8] . While lactate dehydrogenase can be found in most tissues, the ability to separate and analyze changes in five isoenzymes increases the usefulness of measuring this enzyme. The lactate dehydrogenase isoenzyme pattern for mononuclear cell leukemia rats is consistent with an interpretation of liver damage. The significant increases in isoenzyme 4 and isoenzyme 5 in the scheduled sacrifice and early death rats in the absence of histological evidence of muscle damage indicate continuous hepatocellular damage. Although increases in isoenzyme 1 have been
correlated specifically with hemolytic anemia in man [I] , no elevation of this isoenzyme was observed in the mononuclear cell leukemia rats. Increases in cathodal lactate dehydrogenase isoenzymes (with greater percent M subunit) have been recorded in rats with severe anemia and carbon monoxide-induced hypoxia [ 1 1, 121. The lactate dehydrogenase isoenzyme pattern observed in the mononuclear cell leukemia rats exhibits a shift toward increased cathodal forms and may be interpreted as increased M form subunit production due to severe hypoxia mediated by the anemia.
Serum alkaline phosphatase is derived primarily from liver, bone, and intestine. Although isoenzyme separation was not done on mononuclear cell leukemia rats, extensive involvement of the liver in this disease suggests the measured alkaline phosphatase was hepatic in origin.
Serum protein electrophoresis revealed marked decreases in the alpha globulin fractions and mild increases in beta globulin fractions of leukemic rats when compared to normal. A mild but significant decrease in albumin was noted in the scheduled sacrifice rats but was not different from normal in the early death rats. This pattern is not consistent with excessive urinary loss, a conclusion supported by the lack of proteinuria. The marked decrease in alpha globulins may be related to decreased synthesis by an acutely damaged liver. The alpha 1 fraction appears to be more sensitive and thus more severely depressed than the alpha 2 fraction. Hemostasis tests on mononuclear cell leukemia rats [ 171 revealed a prolonged prothrombin time with normal partial thromboplastin time, suggesting deficiency of Factor VII, a vitamin K dependent factor often depressed in liver disease.
The mild increases in beta globulins may be related to liver disease or alterations in lipid metabolism [ 131. Failure of a compromised liver to effectively clear antigens of intestinal origin might stimulate synthesis of immunoglobulin classes which migrate in the beta fraction. In either case, changes in these fractions were mild and undoubtedly of less significance than the alpha globulin decreases.
The finding of (fecal) occult blood in one rat indicates that this pathway may play a small role in the pathogenesis of the anemia [ 171. It was noted that significant thrombocytopenia accompanies mononuclear cell leukemia so some blood loss through the intestine is not surprising. However, the major pathogenetic mechanism of anemia is undoubtedly immune-mediated intravascular hemolysis.
Serum biochemical analysis of F344 rats with mononuclear cell leukemia supports the previous conclusions from morphological and hematological studies. The severe anemia which accompanies the disease is hemolytic. It is the cause of the high bilirubin levels which contribute to the clinically observed jaundice. In addition, the anemia and its associated anoxia are the principal determinants of the hepatic degeneration and necrosis which are reflected in elevation of several liver-related enzymes. Depression of liver function results in regurgitation of conjugated bilirubin which is reflected by bilirubinuria and increased urine urobilinogen. Finally, the acute changes observed in the liver are expressed as decreased synthesis of important regulatory proteins. ' f uI.
